Do you want to read an article? Please log in or register.
Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients
Pulmonary Hypertension
RECOMMENDED
Related content
RECOMMENDED
Pulmonary Hypertension
Risk Assessment in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
Eur Respir J.
Humbert M, Farber HW, Ghofrani HA, Benza RL, Busse D, Meier C, Hoeper MM
doi: 10.1183/13993003.
Pulmonary Hypertension
The impact of patient choice on survival in chronic thromboembolic pulmonary hypertension
Eur Respir J.
Quadery SR, Swift AJ, Billings C, Thompson A, Elliot CA, Hurdman J, Charalampopoulos A, Sabroe I, Armstrong I, Hamilton N, Sephton P, Garrod S, Pepke-Zaba J, Jenkins DP, Screaton N, Rothman AM, Lawrie A, Cleveland T, Thomas S, Rajaram S, Hill C, Davies C, Johns CS, Wild JM, Condliffe R, Kiely DG
doi: 10.1183/13993003.
RECOMMENDED
Pulmonary Hypertension
Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study)
Respir Res.
Marra AM, Halank M, Benjamin N, Bossone E, Cittadini A, Eichstaedt CA, Egenlauf B, Harutyunova S, Fischer C, Gall H, Ghofrani HA, Hoeper MM, Lange TJ, Olsson KM, Klose H, Grünig E
doi: 10.1186/s12931-018-0957-y.
Pulmonary Hypertension
Chronic Thromboembolic Pulmonary Hypertension Cases Cluster in Families
Chest.
Dodson MW, Allen-Brady K, Brown LM, Elliott CG, Cannon-Albright LA
doi: 10.1016/j.chest.
RECOMMENDED
Pulmonary Hypertension
Subcutaneous treprostinil for the treatment of severe non-operable chronic thromboembolic pulmonary hypertension (CTREPH): a double-blind, phase 3, randomised controlled trial
Lancet Respir Med.
Sadushi-Kolici R, Jansa P, Kopec G, Torbicki A, Skoro-Sajer N, Campean IA, Halank M, Simkova I, Karlocai K, Steringer-Mascherbauer R, Samarzija M, Salobir B, Klepetko W, Lindner J, Lang IM
doi: 10.1016/S2213-2600
RECOMMENDED
Pulmonary Hypertension
Epidemiology and Management of Chronic Thromboembolic Pulmonary Hypertension in Greece. Real-World Data from the Hellenic Pulmonary Hypertension Registry (HOPE)
★ 1
Recommended by
Dr Martin Frey, Faculty Member
J Clin Med
Demerouti E, Karyofyllis P, Voudris V, Boutsikou M, Anastasiadis G, Anthi A, Arvanitaki A, Athanassopoulos G, Avgeropoulou A, Brili S, Feloukidis C, Frantzeskaki F, Karatasakis G, Karvounis H, Konstantonis D, Mitrouska I, Mouratoglou S, Naka KK, Orfanos SE, Panagiotidou E, Pitsiou G, Pitsis A, Stamatopoulou V, Stanopoulos I, Thomaidis A, Tsangaris I, Tsiapras D, Giannakoulas G, Manginas A, On Behalf Of The Hellenic Society For The Study Of Pulmonary Hypertension Hssph
doi: 10.3390/jcm10194547
RECOMMENDED
Pulmonary Hypertension
CAMPHOR score: patient-reported outcomes are improved by pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension (CTEPH)
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Eur Respir J.
Newnham M, Bunclark K, Abraham N, Ali S, Amaral-Almeida L, Cannon JE, Doughty N, Ng C, Ponnaberanam A, Sheares K, Speed N, Taboada D, Toshner M, Tsui S, Jenkins DP, Pepke-Zaba J
doi: 10.1183/13993003.02096-2019.
RECOMMENDED
Pulmonary Hypertension
Pregnancy-associated plasma protein A - a new indicator of pulmonary vascular remodeling in chronic thromboembolic pulmonary hypertension?
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Respir Res.
Kriechbaum SD, Rudolph F, Wiedenroth CB, Mielzarek L, Haas M, Guth S, Hamm CW, Mayer E, Liebetrau C, Keller T
doi: 10.1186/s12931-020-01472-3.
COMMENTED
Pulmonary Hypertension
Effect of domiciliary oxygen therapy on exercise capacity and quality of life in patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension: a randomised, placebo-controlled trial
Eur Respir J.
Ulrich S, Saxer S, Hasler ED, Schwarz EI, Schneider SR, Furian M, Bader PR, Lichtblau M, Bloch KE
doi: 10.1183/13993003.002762019.